Drugmaker Roche’s US Biotech Unit Pulls DEI Targets From Website
- Company websites still include broad commitments to diversity
- Genentech as a government contractor must abide by new rules
This article is for subscribers only.
Roche Holding AG’s US unit removed diversity and inclusion targets from its website, the latest in a series of publicly traded companies to bow to US President Donald Trump’s push against equal opportunity programs.
Genentech had aimed by this year to double Black and Hispanic representation of directors and officers and extended leadership, among a range of commitments listed on reports and a version of its diversity website archived by the Wayback Machine.